Trial Profile
A retrospective,cohort study to evaluate the efficacy of Abiraterone acetate and Enzalutamide in patients with Prostate cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Enzalutamide (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 07 Oct 2016 New trial record